Search
for
Sort by
Research 241–270 of 410
- Finasteride Use Is Associated with Higher Odds of Obstructive Sleep Apnea: Results from the US Food and Drug Administration Adverse Events Reporting System.
- Finasteride Use Is Associated with Higher Odds of Obstructive Sleep Apnea: Results from the US Food and Drug Administration Adverse Events Reporting System.
- Cepharanthine: An update of its mode of action, pharmacological properties and medical applications
- Adverse effects of 5α-reductase inhibitors: What do we know, don’t know, and need to know?
- Appropriateness of oral drugs for long-term treatment of lower urinary tract symptoms in older persons: results of a systematic literature review and international consensus validation process (LUTS-FORTA 2014)
- Androgenetic Alopecia: An Update of Treatment Options
- A bibliometric analysis of T cell and atherosclerosis
- Indian Medicinal Herbs and Formulations for Alzheimer’s Disease, from Traditional Knowledge to Scientific Assessment
- Association of Suicidality and Depression With 5α-Reductase Inhibitors
- Vitamin D Concentrations are Decreased in Patients with Alopecia Areata
- Persistent erectile dysfunction in men exposed to the 5α-reductase inhibitors, finasteride, or dutasteride
- An overview of JAK/STAT pathways and JAK inhibition in alopecia areata
- How drug repurposing can advance drug discovery: challenges and opportunities
- Investigation of the Plausibility of 5-Alpha-Reductase Inhibitor Syndrome
- Adverse event reporting of four anti-Calcitonin gene-related peptide monoclonal antibodies for migraine prevention: a real-world study based on the FDA adverse event reporting system
- Is There a Role for Antiandrogen Therapy for Hidradenitis Suppurativa? A Systematic Review of Published Data
- Risks and side effects in the medical management of benign prostatic hyperplasia
- Bioengineered Skin Intended as In Vitro Model for Pharmacosmetics, Skin Disease Study and Environmental Skin Impact Analysis
- Differences in reproductive toxicology between alopecia drugs: an analysis on adverse events among female and male cases
- Current Status of PRP Manufacturing Requirements & European Regulatory Frameworks: Practical Tools for the Appropriate Implementation of PRP Therapies in Musculoskeletal Regenerative Medicine
- Colchicine in Managing Skin Conditions: A Systematic Review
- British Association of Dermatologists living guideline for managing people with alopecia areata 2024
- Maintenance, withdrawal, and re-treatment with ritlecitinib and brepocitinib in patients with alopecia areata in a single-blind extension of a phase 2a randomized clinical trial
- Social media for arthritis-related comparative effectiveness and safety research and the impact of direct-to-consumer advertising
- Severe Infliximab-Induced Alopecia and Scalp Psoriasis in a Woman with Crohn’s Disease: Dramatic Improvement after Drug Discontinuation and Treatment with Adjuvant Systemic and Topical Therapies
- Nanofiber-mediated sequential photothermal antibacteria and macrophage polarization for healing MRSA-infected diabetic wounds
- A Comprehensive Review of Acne Vulgaris
- Alterations of gut microbiota composition in post-finasteride patients: a pilot study
- Chronic overlapping pain conditions and nociplastic pain
- New changes in pregnancy and lactation labelling: Review of dermatologic drugs